Status:
COMPLETED
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Recurrent Ovarian Cancer
Eligibility:
FEMALE
18-80 years
Phase:
PHASE2
Brief Summary
This trial aims to assess efficacy and safety of an intraperitoneal, aerosol, high-pressure chemotherapy in women with recurrent ovarian cancer
Detailed Description
This study aims to investigate the therapeutic efficacy of PIPAC using doxorubicin and cisplatin in women with recurrent ovarian cancer and disease progression with peritoneal carcinomatosis. The prim...
Eligibility Criteria
Inclusion
- at least 2 lines of previous chemotherapy
- recurrent ovarian cancer
- patient is mobile
- informed consent
Exclusion
- ileus
- necessity of parenteral nutrition
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01809379
Start Date
February 1 2013
End Date
September 1 2014
Last Update
July 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruhr University Bochum
Bochum, North Rhine-Westphalia, Germany, 44623